;

Are the Earnings at West Pharmaceutical Services Hiding Something?

Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company’s economic output. That’s because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls. Earnings’ unreliability is one of the reasons Foolish investors often [...]

Posted by admin on April 3rd, 2012 | No Comments Posted in Chinese Stocks, Top Stocks To Buy
;

Antares Pharma Inc. (AIS) Licenses Rights to Oxybutynin Gel to Daewoong Pharmaceuticals

Yesterday, Antares Pharma Inc. (AMEX: AIS)?announced that it has licensed its Oxybutynin Gel 3% to Daewoong Pharmaceuticals Co. Ltd., exclusively, for marketing in South Korea. Antares will receive upfront payments and regulatory and sales based milestones, in addition to royalties on net sales for the product. The FDA-approved Oxybutynin Gel has demonstrated to be an [...]

Posted by admin on January 22nd, 2012 | No Comments Posted in Chinese Stocks, Top Stocks